Evaxion Biotech A/S Sponsored ADR (EVAX) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $30.67 | $70.00 | $8.00 | 829.39% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Evaxion Biotech A/S Sponsored ADR comes to $30.67. The forecasts range from a low of $8.00 to a high of $70.00. The average price target represents an increase of 829.39% from the last closing price of $3.30.
Analyst Price Targets (3 )
Broker Rating
Evaxion Biotech A/S Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 6/4/2024 | Lake Street Capital Markets | Thomas Flaten | Strong Buy | Strong Buy |
| 6/4/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Strong Buy | Strong Buy |
| 4/3/2024 | LadenburgThalmann | Ahu Demir | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.00 |
| ABR (Last week) | 1.00 |
| # of Recs in ABR | 3 |
| Average Target Price | $30.67 |
| LT Growth Rate | NA |
| Industry | Medical - Biomedical and Genetics |
| Industry Rank by ABR | 75 of 252 |
| Current Quarter EPS Est: | NA |